Mannkind (MNKD) Stock: Buy, Sell, or Hold?
MNKD - Mannkind Corporation
$3.20
0.15 (4.92%)
â˛
5d:
+0.31%
30d:
-4.19%
90d:
-22.52%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 04, 2026
12d
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Oct 21, 2026 at $3.08 · last confirmed Oct 21, 2026
Strength: 7.7/10
Get Alerted When MNKD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: MNKD is fairly priced but lacks strong directional signals. At -3.5% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: MNKD is fairly priced but lacks strong directional signals. At -3.5% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: MNKD is currently trading at $3.20, which is considered slightly low relative to its 30-day fair value range of $3.14 to $3.68. From a valuation perspective, the stock is trading at a discount (Forward PE: 22.6) compared to its historical average (25.2). Remarkably, the market is currently pricing in an annual earnings decline of 3.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, MNKD is in a downtrend. Immediate support is located at $2.90, while resistance sits at $3.40. The stock is showing strong short-term momentum, up 4.9% recently.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $8.08 (+165.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MNKD is in a downtrend. Immediate support is located at $2.90, while resistance sits at $3.40. The stock is showing strong short-term momentum, up 4.9% recently.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $8.08 (+165.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$3.14 -
$3.68
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.3%
Protect Your Profits
Holding MNKD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.9%)
- BULLISH: Trading 165.0% below Wall St target ($8.08)
- WARNING: Composite score 51/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.14 -
$3.68
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$2.90
Resistance Level
$3.41
Current Trend
Downtrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
22.59
Wall Street Target
$8.08
(+165.0%)
Revenue Growth (YoY)
42.9%
Earnings Growth (YoY)
-34.9%
Profit Margin
-11.1%
Valuation Discount vs History
-3.5% cheaper
PE vs Historical
22.6 vs 25.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.5%
(market-implied from PE analysis)
1-Year Target
$2.94
(-4%)
2-Year Target
$2.84
(-7%)
3-Year Target
$2.74
(-10%)
3-Yr Target (if PE normalizes)
(PE: 23â25)
$3.06
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.6, Growth: 440.0%)
$10.29
(+238%)
Base:
(SPY PE: 19.9, Growth: 440.0%)
$9.05
(+197%)
Bear:
(PE: 16.9, Growth: 440.0%)
$7.69
(+152%)
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 22.6 to 25.2
Stabilization Target:
$3.40
(+11.5%)
PE Expansion Potential:
+11.5%
Share & Embed Analysis
Last updated: October 22, 2026 4:51 PM ET
Data refreshes hourly during market hours. Next update: 5:51 PM
Data refreshes hourly during market hours. Next update: 5:51 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MNKD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 58 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
TSHA
Taysha Gene Therapies Inc |
STRONG BUY
13 analysts |
$13 | 61 BUY |
|
TRVI
Trevi Therapeutics Inc |
STRONG BUY
11 analysts |
$28 | 69 BUY |
|
APLS
Apellis Pharmaceuticals âĻ |
BUY
22 analysts |
$41 | 50 HOLD |
Advanced MNKD Option Strategies
Professional options setups generated by AI based on today's MNKD price and gamma walls.
